Edition:
United States

PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

2.87USD
22 Nov 2017
Change (% chg)

$-0.01 (-0.35%)
Prev Close
$2.88
Open
$2.90
Day's High
$2.90
Day's Low
$2.85
Volume
227,246
Avg. Vol
464,370
52-wk High
$3.55
52-wk Low
$1.93

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.10 December 24 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2 59.95 74.60 45.30 43.87
Quarter Ending Mar-18 2 57.30 72.50 42.10 --
Year Ending Dec-17 3 306.37 326.60 295.20 199.09
Year Ending Dec-18 3 194.03 307.80 104.20 183.89
Earnings (per share)
Quarter Ending Dec-17 2 0.10 0.18 0.03 -0.01
Quarter Ending Mar-18 2 0.10 0.20 0.01 --
Year Ending Dec-17 3 0.65 0.74 0.60 0.23
Year Ending Dec-18 3 0.31 0.91 -0.07 0.22

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 61.86 62.75 0.89 1.44
Quarter Ending Jun-17 56.30 143.84 87.54 155.48
Quarter Ending Mar-17 50.23 45.44 4.79 9.54
Quarter Ending Dec-16 56.37 66.49 10.13 17.96
Quarter Ending Sep-16 50.69 53.64 2.95 5.82

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 59.95 59.95 63.49 63.49 43.87
Quarter Ending Mar-18 57.30 57.30 67.86 67.86 --
Year Ending Dec-17 306.37 296.03 297.81 297.81 199.09
Year Ending Dec-18 194.03 200.03 185.39 185.39 183.89

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 1
Quarter Ending Mar-18 0 0 1 0
Year Ending Dec-17 1 0 2 1
Year Ending Dec-18 0 1 2 1
Earnings